Back
Vir Biotechnology Vs. Arbutus Biopharma Industry Stock Comparison
Sell
19
VIR
Vir Biotechnology
Last Price:
9.25
Seasonality Move:
40.05%
Sell
41
ABUS
Arbutus Biopharma
Last Price:
3.65
Seasonality Move:
13.65%
Sell
19
Vir Biotechnology (VIR)
is a Sell
Is Vir Biotechnology a Buy, Sell or Hold?
- The current Vir Biotechnology [VIR] share price is $9.87. The Score for VIR is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- VIR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.74. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VIR Stock Price Chart
What is Vir Biotechnology's stock price today?
-
The Vir Biotechnology share price today is $9.87
The current trend is moderately bullish and VIR is experiencing slight selling pressure.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
VIR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 70.45 | Buy |
| Chaikin Money Flow: | 7934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.18 - 9.12) | Buy |
| Bollinger Bands (100): | (7.58 - 9.48) | Buy |
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 39.75 | Sell |
| Chaikin Money Flow: | -753104 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.79 - 4.07) | Sell |
| Bollinger Bands (100): | (3.46 - 4.16) | Sell |
VIR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.4 | Buy |
| 20-day SMA: | 8.33 | Buy |
| 50-day SMA: | 7.93 | Buy |
| 200-day SMA: | 9.22 | Buy |
| 8-day EMA: | 9.37 | Buy |
| 20-day EMA: | 8.66 | Buy |
| 50-day EMA: | 8.32 | Buy |
| 200-day EMA: | 9.54 | Buy |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.85 | Sell |
| 20-day SMA: | 3.97 | Sell |
| 50-day SMA: | 4.03 | Sell |
| 200-day SMA: | 3.33 | Buy |
| 8-day EMA: | 3.83 | Sell |
| 20-day EMA: | 3.91 | Sell |
| 50-day EMA: | 3.91 | Sell |
| 200-day EMA: | 3.42 | Buy |
Vir Biotechnology Earnings Growth & VIR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.10 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Vir Biotechnology Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arbutus Biopharma Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||